Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults
View ORCID ProfileH Ward, View ORCID ProfileC Atchison, M Whitaker, View ORCID ProfileKEC Ainslie, J Elliott, L Okell, R Redd, View ORCID ProfileD Ashby, View ORCID ProfileCA Donnelly, View ORCID ProfileW Barclay, View ORCID ProfileA Darzi, G Cooke, View ORCID ProfileS Riley, P Elliott
doi: https://doi.org/10.1101/2020.08.12.20173690
H Ward
1School of Public Health, Imperial College London
2Imperial College Healthcare NHS Trust
6National Institute for Health Research Imperial Biomedical Research Centre
C Atchison
1School of Public Health, Imperial College London
2Imperial College Healthcare NHS Trust
M Whitaker
1School of Public Health, Imperial College London
KEC Ainslie
1School of Public Health, Imperial College London
3MRC Centre for Global infectious Disease Analysis, School of Public Health, Imperial College London
J Elliott
1School of Public Health, Imperial College London
L Okell
1School of Public Health, Imperial College London
3MRC Centre for Global infectious Disease Analysis, School of Public Health, Imperial College London
R Redd
1School of Public Health, Imperial College London
D Ashby
1School of Public Health, Imperial College London
CA Donnelly
1School of Public Health, Imperial College London
3MRC Centre for Global infectious Disease Analysis, School of Public Health, Imperial College London
4Department of Statistics, University of Oxford
W Barclay
2Imperial College Healthcare NHS Trust
5Department of Infectious Disease, Imperial College London
A Darzi
7Institute of Global Health Innovation at Imperial College London
G Cooke
2Imperial College Healthcare NHS Trust
5Department of Infectious Disease, Imperial College London
6National Institute for Health Research Imperial Biomedical Research Centre
S Riley
1School of Public Health, Imperial College London
3MRC Centre for Global infectious Disease Analysis, School of Public Health, Imperial College London
P Elliott
1School of Public Health, Imperial College London
2Imperial College Healthcare NHS Trust
6National Institute for Health Research Imperial Biomedical Research Centre
8MRC Centre for Environment and Health, School of Public Health, Imperial College London
Article usage
Posted August 14, 2020.
Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults
H Ward, C Atchison, M Whitaker, KEC Ainslie, J Elliott, L Okell, R Redd, D Ashby, CA Donnelly, W Barclay, A Darzi, G Cooke, S Riley, P Elliott
medRxiv 2020.08.12.20173690; doi: https://doi.org/10.1101/2020.08.12.20173690
Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults
H Ward, C Atchison, M Whitaker, KEC Ainslie, J Elliott, L Okell, R Redd, D Ashby, CA Donnelly, W Barclay, A Darzi, G Cooke, S Riley, P Elliott
medRxiv 2020.08.12.20173690; doi: https://doi.org/10.1101/2020.08.12.20173690
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (708)
- Anesthesia (199)
- Cardiovascular Medicine (2908)
- Dermatology (249)
- Emergency Medicine (436)
- Epidemiology (12679)
- Forensic Medicine (10)
- Gastroenterology (823)
- Genetic and Genomic Medicine (4534)
- Geriatric Medicine (412)
- Health Economics (723)
- Health Informatics (2897)
- Health Policy (1066)
- Hematology (383)
- HIV/AIDS (918)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4302)
- Nursing (233)
- Nutrition (631)
- Oncology (2250)
- Ophthalmology (640)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (276)
- Palliative Medicine (83)
- Pathology (493)
- Pediatrics (1192)
- Primary Care Research (491)
- Public and Global Health (6884)
- Radiology and Imaging (1515)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (482)
- Toxicology (60)
- Transplantation (208)
- Urology (178)